We are live on
!
Find out more
LSA
Leonteq Securities AG Portfolio holdings
AUM
$2.91B
1-Year Est. Return
56.5%
This Fund
S&P 500
This Quarter
Est. Return
+0.57%
1 Year Est. Return
+56.5%
3 Year Est. Return
+74.72%
5 Year Est. Return
+9.84%
10 Year Est. Return
–
AUM
$2.78B
AUM Growth
+$435M
(+19%)
Cap. Flow
+$389M
Cap. Flow
% of AUM
13.99%
Top 10 Holdings %
Top 10 Hldgs %
27.16%
Holding
1,362
New
238
Increased
434
Reduced
434
Closed
108
Avg Time Held Equity + Options
2.6
quarters
Top 10 Avg Time Held Equity + Options
2.1
quarters
Top 20 Avg Time Held Equity + Options
2.4
quarters
Avg Time Held Equity only
2.7
quarters
Top 10 Avg Time Held Equity only
2.3
quarters
Top 20 Avg Time Held Equity only
2.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$63.5M |
| 2 |
XYZ
Block Inc
XYZ
|
+$53.5M |
| 3 |
Meta Platforms (Facebook)
META
|
+$48M |
| 4 |
Moderna
MRNA
|
+$29.8M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$22.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$21M |
| 2 |
Baidu
BIDU
|
+$16.7M |
| 3 |
Micron Technology
MU
|
+$16.5M |
| 4 |
Microsoft
MSFT
|
+$15.3M |
| 5 |
Mastercard
MA
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.22% |
| 2 | Miscellaneous | 20.32% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Communication Services | 14.07% |
| 5 | Healthcare | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1076
Zai Lab
ZLAB
$2.75B
| $17.2K | ﹤0.01% |
+274
| New | +$23.2K |
2021 Q4
0 quarters
|
|
1077
Copa Holdings
CPA
$5.57B
| $17.1K | ﹤0.01% |
207
+171
| +475% | +$13.4K |
2020 Q4
4 quarters
|
|
|
CERE
1078
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $16.9K | ﹤0.01% |
+521
| New | +$18.4K |
2021 Q4
0 quarters
|
|
|
NTCO
1079
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $16.8K | ﹤0.01% |
1,814
+514
| +40% | +$6.27K |
2021 Q2
2 quarters
|
|
1080
Fathom Holdings
FTHM
$8.03M
| $16.6K | ﹤0.01% |
812
| – | – |
2021 Q3
1 quarter
|
|
1081
Toll Brothers
TOL
$12.4B
| $16.6K | ﹤0.01% |
229
-4,253
| -95% | -$273K |
2020 Q4
4 quarters
|
|
1082
Xenon Pharmaceuticals
XENE
$3.64B
| $16.6K | ﹤0.01% |
+530
| New | +$15.8K |
2021 Q4
0 quarters
|
|
1083
Veeco
VECO
$3.4B
| $16.5K | ﹤0.01% |
579
+15
| +3% | +$382 |
2020 Q4
4 quarters
|
|
|
AGNT
1084
AGNT Inc
AGNT
$617M
| $16.5K | ﹤0.01% |
489
| – | – |
2021 Q3
1 quarter
|
|
1085
Mercury Systems
MRCY
$5.11B
| $16.5K | ﹤0.01% |
299
+39
| +15% | +$1.98K |
2020 Q4
4 quarters
|
|
|
BCYC
1086
Bicycle Therapeutics
BCYC
$258M
| $16.4K | ﹤0.01% |
+270
| New | +$14.9K |
2021 Q4
0 quarters
|
|
1087
Sylvamo
SLVM
$1.28B
| $16.4K | ﹤0.01% |
+589
| New | +$17.2K |
2021 Q4
0 quarters
|
|
|
P
1088
Everpure Inc
P
$47.7B
| $16.3K | ﹤0.01% |
500
| – | – |
2020 Q4
4 quarters
|
|
|
ITCI
1089
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $16.2K | ﹤0.01% |
+310
| New | +$13K |
2021 Q4
0 quarters
|
|
1090
Comtech Telecommunications
CMTL
$38.4M
| $16.2K | ﹤0.01% |
684
+194
| +40% | +$4.76K |
2021 Q2
2 quarters
|
|
1091
Ascendis Pharma A/S
ASND
$15.1B
| $16.1K | ﹤0.01% |
+120
| New | +$17.9K |
2021 Q4
0 quarters
|
|
1092
Protagonist Therapeutics
PTGX
$8.99B
| $16.1K | ﹤0.01% |
+470
| New | +$14.9K |
2021 Q4
0 quarters
|
|
1093
MKS Inc
MKSI
$18.7B
| $16K | ﹤0.01% |
92
| – | – |
2021 Q3
1 quarter
|
|
1094
Conduent
CNDT
$264M
| $16K | ﹤0.01% |
3,000
+1,000
| +50% | +$5.97K |
2021 Q2
2 quarters
|
|
|
IMGN
1095
DELISTED
Immunogen Inc
IMGN
| $15.9K | ﹤0.01% |
+2,140
| New | +$13.3K |
2021 Q4
0 quarters
|
|
1096
Shift4
FOUR
$2.92B
| $15.9K | ﹤0.01% |
274
| – | – |
2021 Q3
1 quarter
|
|
1097
Keros Therapeutics
KROS
$223M
| $15.8K | ﹤0.01% |
+270
| New | +$13.5K |
2021 Q4
0 quarters
|
|
1098
Harmony Biosciences
HRMY
$2.32B
| $15.8K | ﹤0.01% |
+370
| New | +$14.7K |
2021 Q4
0 quarters
|
|
|
INBX
1099
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $15.7K | ﹤0.01% |
+360
| New | +$14.4K |
2021 Q4
0 quarters
|
|
1100
Helmerich & Payne
HP
$3.86B
| $15.7K | ﹤0.01% |
662
-28,130
| -98% | -$801K |
2020 Q4
4 quarters
|
|
Similar funds
ACM
HWA
GA
BWL
SCM
ISS
RAM
WG
Leonteq Securities AG's Q4 2021 Portfolio in Review
As of Q4 2021, Leonteq Securities AG held 1,362 positions worth $2.78B, up 19% from $2.34B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Leonteq Securities AG deployed $389M of net new capital in Q4 2021, opening 238 new positions and adding to 434 existing holdings. Its largest new stake was IBM: 51,793 shares worth $6.92M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $21M trimmed.
- Leonteq Securities AG's largest Q4 2021 buy was IBM: 51,793 shares worth $6.92M.
- Leonteq Securities AG added most to PayPal in Q4 2021, an estimated $63.5M increase.
- Leonteq Securities AG's biggest Q4 2021 reduction was Alibaba, cutting an estimated $21M.
- Leonteq Securities AG fully exited Colgate-Palmolive in Q4 2021, selling an estimated $2.2M.
- Leonteq Securities AG's ten largest holdings make up 27% of its $2.78B portfolio in Q4 2021.
- Leonteq Securities AG opened 238 new positions and closed 108 in Q4 2021.
- Leonteq Securities AG's portfolio value rose 19% quarter-over-quarter to $2.78B.
Based on Leonteq Securities AG's 13F filing for Q4 2021, filed 26 Mar 2026.